-
Mashup Score: 23Louis M. Staudt, M.D., Ph.D. - 3 day(s) ago
Dr. Staudt pioneered the use of gene expression profiling to discover molecularly and clinically distinct cancer subtypes and to predict response to therapy. He defined molecular subtypes of lymphoma that were previously unrecognized but are now viewed as distinct diseases that arise from different stages of B cell differentiation, utilize different oncogenic mechanisms and offer new therapeutic targets.
Source: ccr.cancer.govCategories: General Medicine NewsTweet
-
Mashup Score: 118
On New Year’s Eve, 2020, Katie Coleman was diagnosed with a very rare form of advanced kidney cancer. She enrolled in a clinical trial led by a collaborative CCR team that gave her the opportunity to have surgery in hopes of removing her tumors.
Source: ccr.cancer.govCategories: General Medicine NewsTweet-
After Katie Coleman was diagnosed with a rare form of advanced #KidneyCancer in 2020, she received treatment through an NCI #ClinicalTrial. Today, she’s an author who raises awareness about rare kidney cancers. https://t.co/zMAYoXnkQD #WorldKidneyDay https://t.co/O8n2wiQ7cc
-
-
Mashup Score: 13Celebrating CCR Careers: Steven Z. Pavletic, M.D., Ph.D. - 8 day(s) ago
Steven Z. Pavletic, M.D., Ph.D., is a renowned expert in chronic graft-versus-host disease, a serious late complication that can happen after allogeneic bone marrow transplants. After serving at the NCI for over 20 years, he is now announcing his retirement.
Source: ccr.cancer.govCategories: General Medicine NewsTweet-
We in the #GVHD field all owe you a huge debt, @StevenPavletic! ❤️🙏 Congratulations on an extremely well earned retirement! https://t.co/nutd1Sj4qT
-
-
Mashup Score: 22Innovative gene therapy shows promise in treating patients with recurrent respiratory papillomatosis - 14 day(s) ago
A clinical trial led by CCR researchers demonstrated the effectiveness of the novel treatment, PRGN-2012, against recurrent respiratory papillomatosis in adults. The results serve as the foundation for an application for accelerated approval to the U.S. Food and Drug Administration (FDA).
Source: ccr.cancer.govCategories: General Medicine NewsTweet-
An NCI #ClinicalTrial has demonstrated the effectiveness of a new #CancerTreatment for recurrent respiratory papillomatosis (RRP). This rare disorder causes non-cancerous tumors throughout the respiratory and digestive tracts. https://t.co/R6jPevBBNQ #HeadAndNeckCancer https://t.co/sZdEX2P7A1
-
-
Mashup Score: 17Clinical trial researching immunotherapy for throat cancer - 18 day(s) ago
A clinical trial led by Clint T. Allen, M.D., Senior Investigator in the Surgical Oncology Program, is researching combination immunotherapy for HPV-associated throat cancer.
Source: ccr.cancer.govCategories: General Medicine NewsTweet-
SEEKING PARTICIPANTS: An NCI #ClinicalTrial is researching immunotherapy for people with #ThroatCancer. The trial will take place at the @NIHClinicalCntr in Maryland, and there is no cost for medical care or participation. https://t.co/mTkKGCOliz #HeadAndNeckCancer https://t.co/IsK0qeYP7D
-
-
Mashup Score: 23Good for Bladder Cancer, Better for Kidney Cancer - 1 month(s) ago
Some discoveries lead you in unexpected directions. When Senior Investigator Andrea Apolo, M.D., sought to explore a new combination of drugs for treating bladder cancer, the results yielded impressive benefits in another tumor type.
Source: ccr.cancer.govCategories: General Medicine News, Oncologists1Tweet-
Some years ago, scientists at NCI’s Center for Cancer Research found that a treatment being tested for bladder cancer was surprisingly effective against kidney cancer. After more testing, the treatment received FDA approval for #KidneyCancer. https://t.co/4cMDU7ktwL #KidneyMonth
-
-
Mashup Score: 16Clinical trial researching immunotherapy for cervical cancer - 4 month(s) ago
A clinical trial led by James L. Gulley, M.D., Ph.D., Co-Director of the Center for Immuno-Oncology, is researching combination immunotherapy for cervical cancer.
Source: ccr.cancer.govCategories: General Medicine News, Oncologists1Tweet-
SEEKING PARTICIPANTS: An NCI-led #ClinicalTrial is testing combination #immunotherapy for people with recurrent or metastatic #CervicalCancer. The trial will take place in Bethesda, MD, and there is no cost for participation. https://t.co/FWBtL46KQB #CervicalHealthMonth https://t.co/H3WdvLI9St
-
-
Mashup Score: 10The First AIDS Drugs - 5 month(s) ago
Faced with the burgeoning HIV/AIDS epidemic in the 1980s, NCI’s intramural program developed the first therapies to effectively treat the disease. The NCI efforts drew upon its established expertise in virology, tumor biology and the immune system and was enabled by the inherent flexibility of the NIH intramural research program to respond quickly to new crises. The discoveries of NCI researchers in the early days of HIV/AIDS were vital in transforming HIV infection from a fatal diagnosis to the manageable condition it is for many today.
Source: ccr.cancer.govCategories: General Medicine News, Oncologists1Tweet-
Did you know that discoveries by NCI researchers were vital in transforming #HIV infection from a fatal condition to the manageable condition it is for many people today? Learn more: https://t.co/wCsodiR0Z0. #WorldAIDSDay https://t.co/WG4dFzEVlA
-
-
Mashup Score: 9Aligned Blog: Celebrating Native American Heritage Month: in conversation with Karina Walters, Ph.D., M.S.W. - 6 month(s) ago
To celebrate Native American Heritage Month, we spoke with Karina Walters, Ph.D., M.S.W., Director of the NIH Tribal Research Health Office (THRO). Dr. Walters, an enrolled member of the Choctaw Nation of Oklahoma, shares what motivates her in working to improve the lives of Indigenous People, her vision for THRO and her own experience as a researcher.
Source: ccr.cancer.govCategories: General Medicine News, Oncologists1Tweet-
In honor of #NativeAmericanHeritageMonth, we are sharing a conversation with Dr. Karina Walters, who directs @NIHs Tribal Research Health Office (THRO). She spoke about efforts to improve the lives of indigenous peoples and her vision for THRO. https://t.co/rRvaWiDHZp https://t.co/XaHy62on1i
-
-
Mashup Score: 2Aligned Blog: Celebrating Native American Heritage Month: in conversation with Karina Walters, Ph.D., M.S.W. - 6 month(s) ago
To celebrate Native American Heritage Month, we spoke with Karina Walters, Ph.D., M.S.W., Director of the NIH Tribal Research Health Office (THRO). Dr. Walters, an enrolled member of the Choctaw Nation of Oklahoma, shares what motivates her in working to improve the lives of Indigenous People, her vision for THRO and her own experience as a researcher.
Source: ccr.cancer.govCategories: General Medicine News, Oncologists1Tweet-
In honor of #NativeAmericanHeritageMonth, we are sharing a conversation with Dr. Karina Walters, who directs @NIHs Tribal Research Health Office (THRO). She spoke about efforts to improve the lives of indigenous peoples and her vision for THRO. https://t.co/rRvaWiDHZp https://t.co/XaHy62on1i
-
Congratulations, Dr. Louis M. Staudt, for earning @AACR's Award for Outstanding Achievement in Blood Cancer Research. Learn about Dr. Staudt's work. https://t.co/NrDOLMElEB #AACR25 #BloodCancer #CancerResearchSavesLives https://t.co/9YYaCkEGRm